title: The cost of new drugs in the treatment of hypertension--the Australian experience.
abstract: The treatment of hypertension by costly new drugs such as the angiotensin converting enzyme inhibitors, means that careful monitoring of health care expenditure is essential. If drugs like simvastatin come to be widely used, costs will mount even more. New drugs cannot be used indiscriminately.
authors.affiliation: Austin Hospital, Heidelberg, Victoria, Australia.
authors.forename: W J
authors.initials: WJ
authors.lastname: Louis
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001315:Australia; D003362:Cost-Benefit Analysis; D006801:Humans; D008148:Lovastatin / Q000031:analogs & derivatives / Q000627:therapeutic use; D019821:Simvastatin
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D008148:Lovastatin; D019821:Simvastatin